Special issues in the management of gliomas in children with neurofibromatosis 1

Journal of Neuro-Oncology

Volumn 28, Issue 2-3, 1996, Pages 257-268

  Pollack, Ian F ^a   Mulvihill, John J ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Brainstem; Children; Glioma; Hemispheric tumor; Hypothalamus; Neurofibromatosis; Optic nerves

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; ETOPOSIDE; LOMUSTINE; MITOLACTOL; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

BRAIN INJURY; BRAIN STEM; DIAGNOSTIC IMAGING; FOLLOW UP; GLIOMA; HEMISPHERE; HUMAN; INFANT; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; REVIEW; VISUAL IMPAIRMENT; VISUAL SYSTEM;

EID: 0029897646     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00250204     Document Type: Review

References (64)

1. Huson SM, Harper PS, Compston DAS: Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111: 1355-1381, 1988
2. Mapstone TB: Neurofibromatosis and central nervous system tumors in childhood. Neurosurg Clin North Am 3: 771-779, 1992
3. Huson SM, Hughes RAC (eds): The Neurofibromatoses. A Pathogenetic and Clinical Overview. Chapman and Hall Medical, New York 487pp, 1994
4. Wallace MR, Marchuk DA, Anderson LB, et al.: Type 1 neu-rofibromatosis gene: identification of a larger transcript disrupted in three NF1 patients. Science 249: 181-186, 1990
5. Xu G, O'Connell P, Viskochil D, et al.: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608, 1990
6. Cawthon RM, Weiss R, Xu G, et al.: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62: 193-201, 1990
7. Ballester R, Marchuk D, Boguski M, et al: The NF1 locus encodes a protein functionally related to mammalian GAP and IRA proteins. Cell 63: 851-859, 1990
8. Basu TN, Gutmann DH, Fletcher JA, et al.: Aberrant regulation of ras proteins in malignant tumors cells from type 1 neurofibromatosis patients. Nature 356: 713-715, 1992
9. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273, 1992
10. Mulvihill JJ: Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Int Med 113: 39-52, 1990
11. Blatt J, Jaffe R, Deutsch M. Adkins JC: Neurofibromatosis and childhood tumors. Cancer 57: 1225-1229, 1986
12. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J: Neurofibromatosis type 1 and childhood cancer. Cancer 72: 2746-2754, 1993
13. Sorensen SA, Mulvihill JJ, Nielsen A: Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. New Engl J Med 314: 1010-1015, 1986
14. Bader JL: Neurofibromatosis and cancer. Ann NY Acad Sci 486: 57-65, 1986
15. National Institutes of Health Consensus Development: Neurofibromatosis. Arch Neurol 45: 575-578, 1988
16. DiMario FJ, Ramsby G, Greenstein R, Langshur S, Dunham B: Neurofibromatosis type 1: Magnetic resonance imaging findings. J Child Neurol 8: 32-39, 1993
17. Duffner PK, Cohen ME, Seidel FG, Shucard DW: The significance of MRI abnormalities in children with neurofibromatosis. Neurology 39: 373-378, 1989
18. Goldstein SM, Curless RG, Post MJD, et al: A new sign of neurofibromatosis on magnetic resonance imaging of children. Arch Neurol 46: 1222-1224, 1989
19. Itoh T, Magnaldi S, White RM, Denckla MB, Hofman K, Naidu S, Bryan RN: Neurofibromatosis type-1 - The evolution of deep gray and white-matter MR abnormalities. Am J Neurorad 15: 1513-1519, 1994
20. Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, Edwards M, Norman D: Neurofibromatosis types 1 and 2: Cranial MR findings. Radiology 172: 527-534, 1989
21. Brown EW, Riccardi VM, Mawad M, Handel S, Goldman A, Bryan RN: MR imaging of optic pathways in patients with neurofibromatosis. AJNR 8: 1031-1036, 1987
22. Sevick RJ, Barkovich AJ, Edwards MSB, Koch T, Berg B, Lempert T: Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR 159: 171-175, 1992
23. Eldridge R, Denckla MB, Bien E, Myers S, Kaiser-Kupfer MI, Pikus A, Schlesinger SL, Parry DM, Dambrosia JM, Zasloff MA, Mulvihill JJ: Neurofibromatosis type l (Recklinghausen's disease). Am J Dis Child 143: 833-837, 1989
24. Varnhagen CK, Lewin S, Das JP, Bowen P, Ma K, Klimek M: Neurofibromatosis and psychological processes. Dev Behav Pediatr 9: 257-265, 1988
25. Ferner RE, Chaudhuri R, Bingham J, Cox T. Hughes RAC: MRI in neurofibromatosis 1. The nature and evolution of increased T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psych 56: 492-495, 1993
26. Listernak R, Charrow J, Greenwald MJ, Esterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114: 788-792, 1989
27. Listernick R, Charrow J: Neurofibromatosis type 1 in childhood. J Pediatr 116: 845-853, 1990
28. Lewis RA, Gerson LP, Axelson K A, et al: Von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata. Ophthalmology 91: 929-935, 1984
29. Stern J, DiGiacinto GV, Housepian EM: Neurofibromatosis and optic glioma: Clinical and morphological correlations. Neurosurgery 4: 524-528, 1979
30. Huffman HJ, Humphreys RP. Drake JM, Rutka JT, Becker LE, Jenkin D, Greenberg M: Optic pathway/hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 19: 186-195, 1993
31. Fletcher WA, Imes RK, Hoyt WF: Chiasmal gliomas: appearance and long-term changes demonstrated by computerized tomography. J Neurosurg 65: 154-159, 1986
32. Dutton JJ: Gliomas of the anterior visual pathway. Survey of Ophthalmology 38: 427-452, 1994
33. Jenkin D, Angyalfi S, Becker L, Berry M, Buncic R, Chan H, et al: Optic nerve glioma in children. Surveillance, resection, or irradiation. Int J Rad Oncol Biol Phys 25: 215-225, 1993
34. Pierce SM, Barnes PD, Loeffler JS, McGinn C, Tarbell NJ: Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer 65: 45-52, 1990
35. Aron A: Panel on diagnosis, incidence, and natural history of optic nerve gliomas. Optic gliomas in neurofibromatosis. Proceedings of Conference Series, Vol 2, New York 37-39, 1989
36. Listernick R, Charrow J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type-I. A longitudinal study. J Pediatr 125: 63-66, 1994
37. Packer RJ: Panel on management and treatment of optic gliomas. Optic gliomas in neurofibromatosis. Proceedings of Conference Series, Vol 2, New York 137-147, 1989
38. Housepian EM, Chi TL: Neurofibromatosis and optic pathways gliomas. J Neuro-Oncol 15: 51-55, 1993
39. Alvord EC Jr, Lofton S: Gliomas of the optic nerve or chiasm. Outcome by patient's age, tumor site, and treatment. J Neurosurg 68: 85-98, 1988
40. Rossi LN, Pastorino G, Scotti G, Gazocchi M, Maninetti MM, Zanolini C, Chiodi A: Early diagnosis of optic glioma in children with neurofibromatosis type-1. Child's Nerv Syst 10: 426-429, 1994
41. North K, Cochineas C, Tang E, Pagan E: Optic gliomas in neurofibromatosis type-1. Role of visual-evoked potentials. Pediatr Neurol 10: 117-123, 1994
42. Wisoff JH, Abbott R. Epstein F: Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73: 661-667, 1990
43. Sutton LN: Surgery as part of the multidisciplinary management of visual pathway gliomas. Pediatr Neurosurg 21: 263, 1994 (abstract)
44. Rodriguez LA, Edwards MSB, Levin VA: Management of hypothalamic gliomas in children: an analysis of 33 cases. Neurosurgery 26: 242-247, 1990
45. Kovalic JJ, Grigsby PW, Shephard MJ, et al: Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18: 927-932, 1990
46. Donahue B: Short- and long-term complications of radiation therapy for pediatric brain tumors. Pediatr Neurosurg 18: 207-217, 1992
47. Duffner PK, Cohen ME, Thomas PRM, Lansky SB: The long-term effects of cranial irradiation on the central nervous system. Cancer 56: 1841-1846, 1985
48. Ellenberg L, McComb JG, Siegel S, Stowe S: Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21: 638-644, 1987
49. Livesey EA, Hindmarsh PC, Brook CGD, Whitton AC, Bloom HJG, Tobias JS, Godlee JN, Britton J: Endocrine disorders following treatment of childhood brain tumors. Br J Cancer 61: 622-625, 1990
50. Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Huffman HJ, Rutka JT: Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 34: 68-78, 1994
51. Kestle JR, Huffman HJ, Mock AR: Moya moya phenomenon after radiation for optic glioma. J Neurosurg 79: 32-35, 1993
52. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, et al: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 23: 79-85, 1988
53. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jackaki R, et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11: 850-856, 1993
54. Petronio J, Edwards MSB, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701-708, 1991
55. Ilgren EB, Kinnier-Wilson LM, Stiller CA: Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Pathol Ann 20: 331-357, 1985
56. Loeffler JS, Rossitch E, Siddon R, Moore MR, Rockoff MA, Alexander E III: Role of stereotactic radiosurgery with a linear accelerator in treatment of intracranial arteriovenous malformations and tumors in children. Pediatrics 85: 775-782, 1990
57. Sposto R, Ertel IJ, Jenkin RDT, et al: The effectiveness of chemotherapy for treatment of high-grade astrocytoma in children: results of a randomized trial. J Neuro-Oncol 7: 165-177, 1989
58. Finlay J, Boyett J, Yates A, Turski P, Wisoff J, Milstein J, McGuire P, el al: A randomized phase III trial of chemotherapy for childhood high-grade astrocytoma. Proc Ann Meet Am Soc Clin Oncol 10: 308, 1991 (abstract)
59. Finlay JL: High-dose chemotherapy followed by bone marrow 'rescue' for recurrent brain tumors. In: Bleyer A, Packer R, Pochedly C (eds) Pediatric Neuro-Oncology: New Trends in Clinical Research. Harwood Publishers, Philadelphia 278-297, 1992
60. Menor E, Marti-Bonmati L, Mulas F, Cortina H, Olague R: Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1. Pediatr Radiol 21: 389-394, 1991
61. Cohen ME, Duffner PK, Heffner RR, Lacey DJ, Brecher M: Prognostic factors in brain stem gliomas. Neurology 36: 602-605, 1986
62. Raffel C, McComb JG, Bodner S, Gilles FE: Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports. Neurosurgery 25: 959-964, 1989
63. Molloy PT, Bilaniuk L, Needle M, Vaughn SN, Zackai E, Phillips PC: Brain-stem mass lesions in neurofibromatosis type-1. A distinct clinical entity. Ann Neurol 36: 549, 1994 (abstract)
64. Pollack IF, Pang D, Albright AL: The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 80: 681-688, 1994